Ormation in A. pleuropneumoniae. However, these findings should also be confirmed

Ormation in A. pleuropneumoniae. However, these findings should also be confirmed in future studies.Supporting InformationFigure S1 Schematic representation of the A. pleuropneumoniae clpP locus. The figure shows the binding locations for the oligonucleotide primers used to amplify the two flanking regions (1249 bp and 1200 bp, respectively) used in the construction of the pEMDclpP plasmid and the diagnostic PCR analysis of the clpP-deleted mutant (367 bp) and wild type A. pleuropneumoniae strains (858 bp). The S8DclpP mutant contains a 491 bp in-frame deletion (shadowed domain) in the clpP gene. (TIF) Figure SPCR identification of the S8DclpP mutant. PCR identification of the S8DclpP mutant using the paired primers clpPJDF/clpPJDR. For lanes 8, the identified S8DclpP mutant (367 bp); for lane M, DL2000 DNA marker was used (from top to bottom: 2000, 1000, 750, 500, 250, and 100 bp); for other lanes, the wild-type S8 strain. (TIF)AcknowledgmentsWe thank Dr. Gerald-F. Gerlach (Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Germany) for the generous 166518-60-1 donation of E. coli b2155 purchase 68181-17-9 strain and vectorRole of ClpP in Actinobacillus pleuropneumoniaepEMOC2. We also thank Dr. Wang and Dr. Shen (Basic Condition and Technology Services Center, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, China) for technical assistance with the SEM experiments.Author ContributionsConceived and designed the experiments: FX CW. Performed the experiments: FX LZ. Analyzed the data: FX GL. Contributed reagents/ materials/analysis tools: YZ SL. Wrote the paper: FX CW.
Ganoderma lucidum is a basidiomycete fungus and has been one of mostly widely used folk remedy in Asia for thousands years. Patients with diseases such as cancer, chronic hepatitis, inflammation, hypertension, and heart disease are treated with G. lucidum [1]. Moreover, the fungal mycelium of G. lucidum is consumed as a tonic to delay senility, improve immunity and enhance health in Taiwan. Ganoderic acids (GAs) are one of major compounds with pharmacological activity found in G. lucidum and these compounds belong to the triterpenoids. More than 130 triterpenoids have been isolated and characterized from the fruiting bodies, cultured mycelium and spores of G. lucidum [1,2]. Ganoderic acids from G. lucidum have been shown to have numerous biological activities including anticancer activity, antiviral activity, hepatoprotective effects, anti-platelet aggregation effects, anti-oxidant activity, hypocholesterolemic activity, and the inhibition of histamine release [1,3]. Recently, ganoderic acid T has been demonstrated to inhibit tumor metastasis by suppression of NF-kB activation [4]. P53 also play important role for anti-invasion of ganoderic acid T in cancer cell [5]. Moreover, several studies indicated thatmitochondria and p53 may be targeted by ganoderic acid T and Me to induce cell apoptosis [6?]. The biosynthesis of triterpenoids has been proposed to proceed via the mevalonate/isoprenoid pathway. Acetyl CoA is used to synthesize mevalonate and isopentenyl-pyrophosphate, which subsequently becomes farnesyl diphosphate [9,10]. Squalene synthase (SQS) and lanosterol synthase (LS) have been proposed to be involved in the formation of squalene and lanosterol, respectively [11,12]. Biosynthesis of the GA end products are thought to be synthesized from lanosterol by a series of oxidation, reduction, hydroxylation, and acet.Ormation in A. pleuropneumoniae. However, these findings should also be confirmed in future studies.Supporting InformationFigure S1 Schematic representation of the A. pleuropneumoniae clpP locus. The figure shows the binding locations for the oligonucleotide primers used to amplify the two flanking regions (1249 bp and 1200 bp, respectively) used in the construction of the pEMDclpP plasmid and the diagnostic PCR analysis of the clpP-deleted mutant (367 bp) and wild type A. pleuropneumoniae strains (858 bp). The S8DclpP mutant contains a 491 bp in-frame deletion (shadowed domain) in the clpP gene. (TIF) Figure SPCR identification of the S8DclpP mutant. PCR identification of the S8DclpP mutant using the paired primers clpPJDF/clpPJDR. For lanes 8, the identified S8DclpP mutant (367 bp); for lane M, DL2000 DNA marker was used (from top to bottom: 2000, 1000, 750, 500, 250, and 100 bp); for other lanes, the wild-type S8 strain. (TIF)AcknowledgmentsWe thank Dr. Gerald-F. Gerlach (Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Germany) for the generous donation of E. coli b2155 strain and vectorRole of ClpP in Actinobacillus pleuropneumoniaepEMOC2. We also thank Dr. Wang and Dr. Shen (Basic Condition and Technology Services Center, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, China) for technical assistance with the SEM experiments.Author ContributionsConceived and designed the experiments: FX CW. Performed the experiments: FX LZ. Analyzed the data: FX GL. Contributed reagents/ materials/analysis tools: YZ SL. Wrote the paper: FX CW.
Ganoderma lucidum is a basidiomycete fungus and has been one of mostly widely used folk remedy in Asia for thousands years. Patients with diseases such as cancer, chronic hepatitis, inflammation, hypertension, and heart disease are treated with G. lucidum [1]. Moreover, the fungal mycelium of G. lucidum is consumed as a tonic to delay senility, improve immunity and enhance health in Taiwan. Ganoderic acids (GAs) are one of major compounds with pharmacological activity found in G. lucidum and these compounds belong to the triterpenoids. More than 130 triterpenoids have been isolated and characterized from the fruiting bodies, cultured mycelium and spores of G. lucidum [1,2]. Ganoderic acids from G. lucidum have been shown to have numerous biological activities including anticancer activity, antiviral activity, hepatoprotective effects, anti-platelet aggregation effects, anti-oxidant activity, hypocholesterolemic activity, and the inhibition of histamine release [1,3]. Recently, ganoderic acid T has been demonstrated to inhibit tumor metastasis by suppression of NF-kB activation [4]. P53 also play important role for anti-invasion of ganoderic acid T in cancer cell [5]. Moreover, several studies indicated thatmitochondria and p53 may be targeted by ganoderic acid T and Me to induce cell apoptosis [6?]. The biosynthesis of triterpenoids has been proposed to proceed via the mevalonate/isoprenoid pathway. Acetyl CoA is used to synthesize mevalonate and isopentenyl-pyrophosphate, which subsequently becomes farnesyl diphosphate [9,10]. Squalene synthase (SQS) and lanosterol synthase (LS) have been proposed to be involved in the formation of squalene and lanosterol, respectively [11,12]. Biosynthesis of the GA end products are thought to be synthesized from lanosterol by a series of oxidation, reduction, hydroxylation, and acet.